# Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB

> **NCT02972697** · PHASE1 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 5 (estimated)

## Conditions studied

- Tuberculosis, Pulmonary

## Interventions

- **RADIATION:** 11C-acetate ligand
- **RADIATION:** FDG ligand

## Key facts

- **NCT ID:** NCT02972697
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2017-09
- **Final completion:** —
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02972697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02972697, "Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02972697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*